January 24, 2012

Wall Street Journal VC Dispatch

Johnson & Johnson Takes Closer Look At PowerVision

PowerVision, which is developing intraocular lenses that can change shape in order to focus, added $4 million over the summer to its Series C round, as medical-device giant Medtronic sought a position in the company. Now Medtronic rival Johnson & Johnson has added to the same round. Neither company currently offers prostheses for the eye, but they could be planning a move into the space.